Description:
Pharmaceutical Manufacturing,Pharmaceutical Preparations,505(b)2 Studies,Ultra sensitive & complex bioanalysis,Respiratory PK (oral and nasal inhalers),Transdermal Patches,Patient Phase I studies (Psychiatric populations),Ultra accelerated turnaround (PK & report within 5 days),Ultra sensitive & complex bioanalysis,Ultra accelerated turnaround (PK & report within 5 days),Ultra sensitive & complex bioanalysis,Ultra accelerated turnaround (PK & report within 5 days) Read More
